Blindness as a complication of subcutaneous nasal steroid injection.
Blindness as a result of steroid injection into areas adjacent to the eyes, namely the interior of the nose and eyelids, has been described in the otolaryngologic and ophthalmologic literature but at no time in the plastic surgery literature. We describe a case of permanent visual loss at the time of injection of a long-acting steroid to the dorsum of the nose for postrhinoplasty scarring. We suggest that before steroid injection for elective procedures, the patient be informed of all possible consequences of complications even if their occurrence is very rare.
Shafir
R
R
Department of Plastic and Reconstructive Surgery, Tel-Aviv Sourasky Medical Center, the Sackler Faculty of Medicine, Tel-Aviv University, Israel. shafir@post.tau.ac.il
Cohen
M
M
Gur
E
E
D000281:Administration, Intranasal; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001766:Blindness / Q000209:etiology*; D002829:Choroid / Q000098:blood supply*; D004487:Edema / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077555:Methylprednisolone Acetate; D009668:Nose Diseases / Q000188:drug therapy / Q000209:etiology; D012164:Retinal Diseases / Q000139:chemically induced* / Q000150:complications; D012225:Rhinoplasty / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced* / Q000150:complications
D000893:Anti-Inflammatory Agents; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone